Skip to main content
Top
Published in: BMC Public Health 1/2013

Open Access 01-12-2013 | Research article

Prevalence and risk factors for diabetic retinopathy in a high-risk Chinese population

Authors: Jiao Wang, Ru-Yi Zhang, Rong-Ping Chen, Jia Sun, Rui Yang, Xiao-Yun Ke, Hui Chen, De-Hong Cai

Published in: BMC Public Health | Issue 1/2013

Login to get access

Abstract

Background

Lifestyle plays an important role in the development of diabetic retinopathy. The lifestyle in Guangzhou is different from other cities in China as the Cantonese prefer eating rice porridge, but not spicy foods. The objectives of this study were to investigate the prevalence and determinants of diabetic retinopathy in a high-risk population of Guangzhou.

Methods

Subjects (619 totals) aged over 45 years old, without known diabetes were recruited from five randomly selected Guangzhou communities in 2009–2010. All participants were invited to complete the Finnish Diabetes Risk Score (FINDRISC) questionnaire. Subjects with FINDRISC score ≥ 9 were included in the study, and underwent an investigation of demographic data, a standardized physical examination, ocular fundus examination, and laboratory analyses. The minimum criterion for diagnosis of diabetic retinopathy was the presence of at least one microaneurysm.

Results

Of 619 subjects, 208 eligible subjects (122 women) with FINDRISC score ≥ 9 were included in the study. The mean age was 69.2 ± 8.5 years. Diabetic retinopathy was detected in 31 subjects, and the prevalence of diabetic retinopathy in subjects with high risk for diabetes was 14.9%. In binary logistic regression analysis, risk factors associated with diabetic retinopathy were history of impaired glucose regulation [odds ratio (OR), 7.194; 95% confidence interval (CI): 1.083, 47.810], higher hemoglobin A1c (HbA1c; OR, 2.912; 95% CI: 1.009, 8.402), higher two-hour postprandial plasma glucose level (OR, 1.014; 95% CI: 1.003, 1.025), and presence of microalbuminuria (OR, 5.387; 95% CI: 1.255, 23.129).

Conclusions

Diabetic retinopathy was prevalent in a high-risk Chinese population from Guangzhou. Histories of impaired glucose regulation and microalbuminuria were strong risk factors for diabetic retinopathy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kempen JH, O’Colmain BJ, Leske MC, Haffner SM, Klein R, Moss SE, et al: Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004, 122 (4): 552-563.CrossRefPubMed Kempen JH, O’Colmain BJ, Leske MC, Haffner SM, Klein R, Moss SE, et al: Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004, 122 (4): 552-563.CrossRefPubMed
2.
go back to reference Cheung N, Wong TY: Diabetic retinopathy and systemic vascular complications. Prog Retin Eye Res. 2008, 27 (2): 161-176. 10.1016/j.preteyeres.2007.12.001.CrossRefPubMed Cheung N, Wong TY: Diabetic retinopathy and systemic vascular complications. Prog Retin Eye Res. 2008, 27 (2): 161-176. 10.1016/j.preteyeres.2007.12.001.CrossRefPubMed
3.
go back to reference Liew G, Wong TY, Mitchell P, Cheung N, Wang JJ: Retinopathy predicts coronary heart disease mortality. Heart. 2008, 95 (5): 391-394. 10.1136/hrt.2008.146670.CrossRefPubMed Liew G, Wong TY, Mitchell P, Cheung N, Wang JJ: Retinopathy predicts coronary heart disease mortality. Heart. 2008, 95 (5): 391-394. 10.1136/hrt.2008.146670.CrossRefPubMed
4.
go back to reference Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al: Prevalence of diabetes among Men and women in china. N Engl J Med. 2010, 362 (12): 1090-1101. 10.1056/NEJMoa0908292.CrossRefPubMed Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al: Prevalence of diabetes among Men and women in china. N Engl J Med. 2010, 362 (12): 1090-1101. 10.1056/NEJMoa0908292.CrossRefPubMed
5.
go back to reference Pang C, Jia L, Jiang S, Liu W, Hou X, Zuo Y, et al: Determination of diabetic retinopathy prevalence and associated risk factors in Chinese diabetic and pre-diabetic subjects: Shanghai diabetic complications study. Diab/Metab Res Reviews. 2012, 28 (3): 276-283.CrossRef Pang C, Jia L, Jiang S, Liu W, Hou X, Zuo Y, et al: Determination of diabetic retinopathy prevalence and associated risk factors in Chinese diabetic and pre-diabetic subjects: Shanghai diabetic complications study. Diab/Metab Res Reviews. 2012, 28 (3): 276-283.CrossRef
6.
go back to reference Lee KM, Sum WM: Prevalence of diabetic retinopathy in patients with recently diagnosed diabetes mellitus. Clin Exp Optometry. 2011, 94 (4): 371-375. 10.1111/j.1444-0938.2010.00574.x.CrossRef Lee KM, Sum WM: Prevalence of diabetic retinopathy in patients with recently diagnosed diabetes mellitus. Clin Exp Optometry. 2011, 94 (4): 371-375. 10.1111/j.1444-0938.2010.00574.x.CrossRef
7.
go back to reference He YH, Jiang GX, Yang Y, Huang HE, Li R, Li XY, et al: Obesity and its associations with hypertension and type 2 diabetes among Chinese adults age 40 years and over. Nutrition. 2009, 25 (11–12): 1143-1149.CrossRefPubMed He YH, Jiang GX, Yang Y, Huang HE, Li R, Li XY, et al: Obesity and its associations with hypertension and type 2 diabetes among Chinese adults age 40 years and over. Nutrition. 2009, 25 (11–12): 1143-1149.CrossRefPubMed
8.
go back to reference Chaiyasit K, Khovidhunkit W, Wittayalertpanya S: Pharmacokinetic and the effect of capsaicin in Capsicum frutescens on decreasing plasma glucose level. J Med Assoc Thai. 2009, 92 (1): 108-113.PubMed Chaiyasit K, Khovidhunkit W, Wittayalertpanya S: Pharmacokinetic and the effect of capsaicin in Capsicum frutescens on decreasing plasma glucose level. J Med Assoc Thai. 2009, 92 (1): 108-113.PubMed
9.
go back to reference Kang JH, Kim C, Han IS, Kawada T, Yu R: Capsaicin, a spicy component of hot peppers, modulates adipokine gene expression and protein release from obese-mouse adipose tissues and isolated adipocytes, and suppresses the inflammatory responses of adipose tissue macrophages. FEBS Lett. 2007, 581 (23): 4389-4396. 10.1016/j.febslet.2007.07.082.CrossRefPubMed Kang JH, Kim C, Han IS, Kawada T, Yu R: Capsaicin, a spicy component of hot peppers, modulates adipokine gene expression and protein release from obese-mouse adipose tissues and isolated adipocytes, and suppresses the inflammatory responses of adipose tissue macrophages. FEBS Lett. 2007, 581 (23): 4389-4396. 10.1016/j.febslet.2007.07.082.CrossRefPubMed
10.
go back to reference Winkler G, Hídvégi T, Vándorfi G, Balogh S, Jermendy G: Prevalence of undiagnosed abnormal glucose tolerance in adult patients cared for by general practitioners in Hungary. Results of a risk-stratified screening based on FINDRISC questionnaire. Med Sci Monit. 2013, 19: 67-72.CrossRefPubMedPubMedCentral Winkler G, Hídvégi T, Vándorfi G, Balogh S, Jermendy G: Prevalence of undiagnosed abnormal glucose tolerance in adult patients cared for by general practitioners in Hungary. Results of a risk-stratified screening based on FINDRISC questionnaire. Med Sci Monit. 2013, 19: 67-72.CrossRefPubMedPubMedCentral
11.
go back to reference Bergmann A, Li J, Wang L, Schulze J, Bornstein SR, Schwarz PE: A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population. Horm Metab Res. 2007, 39 (9): 677-682. 10.1055/s-2007-985353.CrossRefPubMed Bergmann A, Li J, Wang L, Schulze J, Bornstein SR, Schwarz PE: A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population. Horm Metab Res. 2007, 39 (9): 677-682. 10.1055/s-2007-985353.CrossRefPubMed
12.
go back to reference Costa B, Barrio F, Piñol JL, Cabré JJ, Mundet X, Sagarra R, et al: Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish diabetes risk score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy. BMC Med. 2013, 11 (1): 45-10.1186/1741-7015-11-45.CrossRefPubMedPubMedCentral Costa B, Barrio F, Piñol JL, Cabré JJ, Mundet X, Sagarra R, et al: Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish diabetes risk score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy. BMC Med. 2013, 11 (1): 45-10.1186/1741-7015-11-45.CrossRefPubMedPubMedCentral
13.
go back to reference Garcia-Alcala H, Soto Vega E, Genestier Tamborero CN, Salinas Palma JL, Hirales Tamez O: Frequency of diabetes, impaired fasting glucose, and glucose intolerance in high-risk groups identified by a FINDRISC survey in Puebla City, Mexico. Diab Metab Syndrome Obes Targets Therapy. 2012, 5: 403-406.CrossRef Garcia-Alcala H, Soto Vega E, Genestier Tamborero CN, Salinas Palma JL, Hirales Tamez O: Frequency of diabetes, impaired fasting glucose, and glucose intolerance in high-risk groups identified by a FINDRISC survey in Puebla City, Mexico. Diab Metab Syndrome Obes Targets Therapy. 2012, 5: 403-406.CrossRef
14.
go back to reference Hellgren MI, Petzold M, Björkelund C, Wedel H, Jansson PA, Lindblad U: Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based study. Diab Med. 2012, 29 (12): 1501-1505. 10.1111/j.1464-5491.2012.03664.x.CrossRef Hellgren MI, Petzold M, Björkelund C, Wedel H, Jansson PA, Lindblad U: Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based study. Diab Med. 2012, 29 (12): 1501-1505. 10.1111/j.1464-5491.2012.03664.x.CrossRef
15.
go back to reference Makrilakis K, Liatis S, Grammatikou S, Perrea D, Katsilambros N: Implementation and effectiveness of the first community lifestyle intervention programme to prevent Type 2 diabetes in Greece. The DE-PLAN study. Diabet Med. 2010, 27 (4): 459-465. 10.1111/j.1464-5491.2010.02918.x.CrossRefPubMed Makrilakis K, Liatis S, Grammatikou S, Perrea D, Katsilambros N: Implementation and effectiveness of the first community lifestyle intervention programme to prevent Type 2 diabetes in Greece. The DE-PLAN study. Diabet Med. 2010, 27 (4): 459-465. 10.1111/j.1464-5491.2010.02918.x.CrossRefPubMed
16.
go back to reference Makrilakis K, Liatis S, Grammatikou S, Perrea D, Stathi C, Tsiligros P, et al: Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece. Diabetes Metab. 2011, 37 (2): 144-151. 10.1016/j.diabet.2010.09.006.CrossRefPubMed Makrilakis K, Liatis S, Grammatikou S, Perrea D, Stathi C, Tsiligros P, et al: Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece. Diabetes Metab. 2011, 37 (2): 144-151. 10.1016/j.diabet.2010.09.006.CrossRefPubMed
17.
go back to reference Saaristo T, Moilanen L, Korpi-Hyövälti E, Vanhala M, Saltevo J, Niskanen L, et al: Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish national diabetes prevention program (FIN-D2D). Diabetes Care. 2010, 33 (10): 2146-2151. 10.2337/dc10-0410.CrossRefPubMedPubMedCentral Saaristo T, Moilanen L, Korpi-Hyövälti E, Vanhala M, Saltevo J, Niskanen L, et al: Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish national diabetes prevention program (FIN-D2D). Diabetes Care. 2010, 33 (10): 2146-2151. 10.2337/dc10-0410.CrossRefPubMedPubMedCentral
18.
go back to reference Tankova T, Chakarova N, Atanassova I, Dakovska L: Evaluation of the Finnish diabetes risk score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes. Diabetes Res Clin Pract. 2011, 92 (1): 46-52. 10.1016/j.diabres.2010.12.020.CrossRefPubMed Tankova T, Chakarova N, Atanassova I, Dakovska L: Evaluation of the Finnish diabetes risk score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes. Diabetes Res Clin Pract. 2011, 92 (1): 46-52. 10.1016/j.diabres.2010.12.020.CrossRefPubMed
19.
go back to reference Wang J, Stancáková A, Kuusisto J, Laakso M: Identification of undiagnosed type 2 diabetic individuals by the finnish diabetes risk score and biochemical and genetic markers: a population-based study of 7232 Finnish men. J Clin Endocrinol Metab. 2010, 95 (8): 3858-3862. 10.1210/jc.2010-0012.CrossRefPubMed Wang J, Stancáková A, Kuusisto J, Laakso M: Identification of undiagnosed type 2 diabetic individuals by the finnish diabetes risk score and biochemical and genetic markers: a population-based study of 7232 Finnish men. J Clin Endocrinol Metab. 2010, 95 (8): 3858-3862. 10.1210/jc.2010-0012.CrossRefPubMed
20.
go back to reference Lindström J, Tuomilehto J: The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003, 26 (3): 725-731. 10.2337/diacare.26.3.725.CrossRefPubMed Lindström J, Tuomilehto J: The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003, 26 (3): 725-731. 10.2337/diacare.26.3.725.CrossRefPubMed
21.
go back to reference Franciosi M, De Berardis G, Rossi MC, Sacco M, Belfiglio M, Pellegrini F, et al: Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study. Diabetes Care. 2005, 28 (5): 1187-1194. 10.2337/diacare.28.5.1187.CrossRefPubMed Franciosi M, De Berardis G, Rossi MC, Sacco M, Belfiglio M, Pellegrini F, et al: Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study. Diabetes Care. 2005, 28 (5): 1187-1194. 10.2337/diacare.28.5.1187.CrossRefPubMed
22.
go back to reference Wong TY, Cheung N, Tay WT, Wang JJ, Aung T, Saw SM, et al: Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology. 2008, 115 (11): 1869-1875. 10.1016/j.ophtha.2008.05.014.CrossRefPubMed Wong TY, Cheung N, Tay WT, Wang JJ, Aung T, Saw SM, et al: Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology. 2008, 115 (11): 1869-1875. 10.1016/j.ophtha.2008.05.014.CrossRefPubMed
23.
go back to reference Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, Davis M, et al: Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003, 110 (9): 1677-1682. 10.1016/S0161-6420(03)00475-5.CrossRefPubMed Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, Davis M, et al: Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003, 110 (9): 1677-1682. 10.1016/S0161-6420(03)00475-5.CrossRefPubMed
24.
go back to reference Department of Noncommunicable Disease Surveillance: Definition, diagnosis and classif ication of diabetes mellitus and its complications: report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus. 1999, Geneva: World Health Organization Department of Noncommunicable Disease Surveillance: Definition, diagnosis and classif ication of diabetes mellitus and its complications: report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus. 1999, Geneva: World Health Organization
25.
go back to reference Guidelines subcommittee: 1999 World health organization-international society of hypertension guidelines for the management of hypertension. J Hypertens. 1999, 17 (2): 151-183. Guidelines subcommittee: 1999 World health organization-international society of hypertension guidelines for the management of hypertension. J Hypertens. 1999, 17 (2): 151-183.
26.
go back to reference Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V: Prevalence of diabetic retinopathy in urban India: the Chennai urban rural epidemiology study (CURES) eye study, I. Invest Ophthalmol Vis Sci. 2005, J46 (7): 2328-2333.CrossRef Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V: Prevalence of diabetic retinopathy in urban India: the Chennai urban rural epidemiology study (CURES) eye study, I. Invest Ophthalmol Vis Sci. 2005, J46 (7): 2328-2333.CrossRef
27.
go back to reference Tapp RJ, Shaw JE, Harper CA, de Courten MP, Balkau B, McCarty DJ, et al: The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care. 2003, 26 (6): 1731-1737. 10.2337/diacare.26.6.1731.CrossRefPubMed Tapp RJ, Shaw JE, Harper CA, de Courten MP, Balkau B, McCarty DJ, et al: The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care. 2003, 26 (6): 1731-1737. 10.2337/diacare.26.6.1731.CrossRefPubMed
28.
go back to reference Kim JH, Kwon HS, Park YM, Lee JH, Kim MS, Yoon KH, et al: Prevalence and associated factors of diabetic retinopathy in rural Korea: the chungju metabolic disease cohort study. J Korean Med Sci. 2011, 26 (8): 1068-10.3346/jkms.2011.26.8.1068.CrossRefPubMedPubMedCentral Kim JH, Kwon HS, Park YM, Lee JH, Kim MS, Yoon KH, et al: Prevalence and associated factors of diabetic retinopathy in rural Korea: the chungju metabolic disease cohort study. J Korean Med Sci. 2011, 26 (8): 1068-10.3346/jkms.2011.26.8.1068.CrossRefPubMedPubMedCentral
29.
go back to reference Mohamed Q, Gillies MC, Wong TY: Management of diabetic retinopathy: a systematic review. JAMA. 2007, 298 (8): 902-916. 10.1001/jama.298.8.902.CrossRefPubMed Mohamed Q, Gillies MC, Wong TY: Management of diabetic retinopathy: a systematic review. JAMA. 2007, 298 (8): 902-916. 10.1001/jama.298.8.902.CrossRefPubMed
30.
go back to reference Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, et al: Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA. 2010, 304 (6): 649-656. 10.1001/jama.2010.1111.CrossRefPubMedPubMedCentral Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, et al: Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA. 2010, 304 (6): 649-656. 10.1001/jama.2010.1111.CrossRefPubMedPubMedCentral
31.
go back to reference Park CY, Park SE, Bae JC, Kim WJ, Park SW, Ha MM, et al: Prevalence of and risk factors for diabetic retinopathy in Koreans with type II diabetes: baseline characteristics of Seoul metropolitan city-diabetes prevention program (SMC-DPP) participants. Brit J Ophthalmol. 2011, 96 (2): 151-155.CrossRef Park CY, Park SE, Bae JC, Kim WJ, Park SW, Ha MM, et al: Prevalence of and risk factors for diabetic retinopathy in Koreans with type II diabetes: baseline characteristics of Seoul metropolitan city-diabetes prevention program (SMC-DPP) participants. Brit J Ophthalmol. 2011, 96 (2): 151-155.CrossRef
32.
go back to reference Xu J, Wei WB, Yuan MX, Yuan SY, Wan G, Zheng YY, et al: Prevalence and risk factors for diabetic retinopathy: the Beijing communities diabetes study 6. Retina. 2012, 32 (2): 322-329. 10.1097/IAE.0b013e31821c4252.CrossRefPubMed Xu J, Wei WB, Yuan MX, Yuan SY, Wan G, Zheng YY, et al: Prevalence and risk factors for diabetic retinopathy: the Beijing communities diabetes study 6. Retina. 2012, 32 (2): 322-329. 10.1097/IAE.0b013e31821c4252.CrossRefPubMed
33.
go back to reference Chen H, Zheng Z, Huang Y, Guo K, Lu J, Zhang L, et al: A microalbuminuria threshold to predict the risk for the development of diabetic retinopathy in type 2 diabetes mellitus patients. PLoS One. 2012, 7 (5): e36718-10.1371/journal.pone.0036718.CrossRefPubMedPubMedCentral Chen H, Zheng Z, Huang Y, Guo K, Lu J, Zhang L, et al: A microalbuminuria threshold to predict the risk for the development of diabetic retinopathy in type 2 diabetes mellitus patients. PLoS One. 2012, 7 (5): e36718-10.1371/journal.pone.0036718.CrossRefPubMedPubMedCentral
34.
go back to reference Cruickshanks KJ, Ritter LL, Klein R, Moss SE: The association of microalbuminuria with diabetic retinopathy. The Wisconsin epidemiologic study of diabetic retinopathy. Ophthalmology. 1993, 100 (6): 862-867.CrossRefPubMed Cruickshanks KJ, Ritter LL, Klein R, Moss SE: The association of microalbuminuria with diabetic retinopathy. The Wisconsin epidemiologic study of diabetic retinopathy. Ophthalmology. 1993, 100 (6): 862-867.CrossRefPubMed
35.
go back to reference Tam TK, Lau CM, Tsang LC, Ng KK, Ho KS, Lai TC: Epidemiological study of diabetic retinopathy in a primary care setting in Hong Kong. Hong Kong Med J. 2005, 11 (6): 438-444.PubMed Tam TK, Lau CM, Tsang LC, Ng KK, Ho KS, Lai TC: Epidemiological study of diabetic retinopathy in a primary care setting in Hong Kong. Hong Kong Med J. 2005, 11 (6): 438-444.PubMed
36.
go back to reference Wang FH, Liang YB, Peng XY, Wang JJ, Zhang F, Wei WB, et al: Risk factors for diabetic retinopathy in a rural Chinese population with type 2 diabetes: the Handan Eye Study. Acta Ophthalmol. 2011, 89 (4): e336-e343. 10.1111/j.1755-3768.2010.02062.x.CrossRefPubMed Wang FH, Liang YB, Peng XY, Wang JJ, Zhang F, Wei WB, et al: Risk factors for diabetic retinopathy in a rural Chinese population with type 2 diabetes: the Handan Eye Study. Acta Ophthalmol. 2011, 89 (4): e336-e343. 10.1111/j.1755-3768.2010.02062.x.CrossRefPubMed
37.
go back to reference Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HA, Holman RR: Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia. 2006, 49 (8): 1761-1769. 10.1007/s00125-006-0297-1.CrossRefPubMed Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HA, Holman RR: Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia. 2006, 49 (8): 1761-1769. 10.1007/s00125-006-0297-1.CrossRefPubMed
38.
go back to reference Huang OS, Lamoureux EL, Tay WT, Tai ES, Wang JJ, Wong TY: Glycemic and blood pressure control in an asian malay population with diabetes and diabetic retinopathy. Arch Ophthalmol. 2010, 128 (9): 1185-1190. 10.1001/archophthalmol.2010.168.CrossRefPubMed Huang OS, Lamoureux EL, Tay WT, Tai ES, Wang JJ, Wong TY: Glycemic and blood pressure control in an asian malay population with diabetes and diabetic retinopathy. Arch Ophthalmol. 2010, 128 (9): 1185-1190. 10.1001/archophthalmol.2010.168.CrossRefPubMed
39.
go back to reference Klein R, Klein BE, Moss SE: Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med. 1996, 124 (1 Pt 2): 90-96.CrossRefPubMed Klein R, Klein BE, Moss SE: Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med. 1996, 124 (1 Pt 2): 90-96.CrossRefPubMed
40.
go back to reference Grosso A, Cheung N, Veglio F, Wong TY: Similarities and differences in early retinal phenotypes in hypertension and diabetes. J Hypertens. 2011, 29 (9): 1667-1675. 10.1097/HJH.0b013e3283496655.CrossRefPubMed Grosso A, Cheung N, Veglio F, Wong TY: Similarities and differences in early retinal phenotypes in hypertension and diabetes. J Hypertens. 2011, 29 (9): 1667-1675. 10.1097/HJH.0b013e3283496655.CrossRefPubMed
Metadata
Title
Prevalence and risk factors for diabetic retinopathy in a high-risk Chinese population
Authors
Jiao Wang
Ru-Yi Zhang
Rong-Ping Chen
Jia Sun
Rui Yang
Xiao-Yun Ke
Hui Chen
De-Hong Cai
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2013
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-13-633

Other articles of this Issue 1/2013

BMC Public Health 1/2013 Go to the issue